Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression

Míreanna comhchosúla

• Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
  de réir: Xun-Xi Lu (14952883)
  Foilsithe / Cruthaithe: (2025)
• Table S3 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
  de réir: Xun-Xi Lu (14952883)
  Foilsithe / Cruthaithe: (2025)
• Table S7 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
  de réir: Xun-Xi Lu (14952883)
  Foilsithe / Cruthaithe: (2025)
• Table S8 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
  de réir: Xun-Xi Lu (14952883)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
  de réir: Ana Vujovic (15207479)
  Foilsithe / Cruthaithe: (2025)